BASi   4Q Revenues: $5.0 million (-22%) 4Q Loss: $721,000 (loss of $389,000 4Q14) FY Revenues: $22.7 million (-8%) FY Earnings: $1.1 million (loss of $1.1 million FY14) Comments: Service revenue in the quarter was down 22% to $3.8 million, negatively impacted by fewer bioequivalence studies and fewer samples received and analyzed. Service revenue for the year was down 7% to $17.8 million. Product revenue in the quarter was $1.1 million, down 25%, and $4.9 million for the year, down...